- Home
- Publications
- Publication Search
- Publication Details
Title
Aldo-Keto Reductases and Cancer Drug Resistance
Authors
Keywords
-
Journal
PHARMACOLOGICAL REVIEWS
Volume 73, Issue 3, Pages 1150-1171
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2021-07-27
DOI
10.1124/pharmrev.120.000122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor
- (2020) Ahmed Morsy et al. ACS Chemical Biology
- Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer
- (2020) Juan M. Cubillos-Angulo et al. PLoS One
- Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells
- (2020) Chen Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs
- (2020) Enrico Girardi et al. Nature Chemical Biology
- Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells
- (2020) Xiaodan Sun et al. Oxidative Medicine and Cellular Longevity
- Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?
- (2020) Tharindu L. Suraweera et al. Antioxidants
- Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells
- (2020) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Bruton’s Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3
- (2020) Anselm Morell et al. Cancers
- Potent and Highly Selective Aldo–Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
- (2019) Kshitij Verma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C3
- (2019) Neslihan Bukum et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing
- (2019) Federico Fabrizio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
- (2019) Wei-Min Chang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Induction of the Antioxidant Response by the Transcription Factor NRF2 Increases Bioactivation of the Mutagenic Air Pollutant 3-Nitrobenzanthrone in Human Lung Cells
- (2019) Jessica R. Murray et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile
- (2018) Eva Novotná et al. ARCHIVES OF TOXICOLOGY
- AKR1C enzymes sustain therapy resistance in paediatric T-ALL
- (2018) Roberta Bortolozzi et al. BRITISH JOURNAL OF CANCER
- Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
- (2018) Agnese Chiara Pippione et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells
- (2018) Kshitij Verma et al. MOLECULAR CANCER THERAPEUTICS
- Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
- (2018) Eva Novotná et al. BIOCHEMICAL PHARMACOLOGY
- Structural and Functional Biology of Aldo-Keto Reductase Steroid Transforming Enzymes
- (2018) Trevor M Penning et al. ENDOCRINE REVIEWS
- AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders
- (2018) Trevor M. Penning MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A catalogue of somatic NRF2 gain-of-function mutations in cancer
- (2018) Michael John Kerins et al. Scientific Reports
- The role of 17βHSDs in breast tissue and breast cancers
- (2018) Keely May McNamara et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
- (2017) Agnese C. Pippione et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Brusatol overcomes chemoresistance through inhibition of protein translation
- (2017) Bryan Harder et al. MOLECULAR CARCINOGENESIS
- Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity
- (2017) Masashi Shiiba et al. ONCOLOGY REPORTS
- CLIC1 Induces Drug Resistance in Human Choriocarcinoma Through Positive Regulation of MRP1
- (2017) Jinhui Wu et al. ONCOLOGY RESEARCH
- Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism
- (2016) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance
- (2016) Toshiyuki Matsunaga et al. FREE RADICAL RESEARCH
- Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer
- (2016) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds
- (2016) Xuyu Zu et al. MOLECULAR CARCINOGENESIS
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases
- (2016) Amity Platt et al. Pharmacogenetics and Genomics
- Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology
- (2016) Jeonghun Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance
- (2016) Jan Hintzpeter et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines
- (2016) Kshitij Verma et al. ACS Medicinal Chemistry Letters
- Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
- (2016) Ryuji Matsumoto et al. Scientific Reports
- Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss
- (2015) Ting Zhong et al. BIOMEDICINE & PHARMACOTHERAPY
- Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
- (2015) C. Liu et al. CANCER RESEARCH
- Nrf2-mediated adaptive response to methyl glyoxal in HepG2 cells involves the induction of AKR7A2
- (2015) Dan Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo–keto reductase 1B10
- (2015) Yoshifumi Morikawa et al. CHEMICO-BIOLOGICAL INTERACTIONS
- ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells
- (2015) K. Powell et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation of Keap1-Nrf2 signaling
- (2015) Yue Guo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
- (2015) Lauren E. Tebay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Structural basis of Keap1 interactions with Nrf2
- (2015) Peter Canning et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia
- (2015) J Flynn et al. LEUKEMIA
- Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
- (2014) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line
- (2014) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
- (2014) Yuantong Tian et al. Diagnostic Pathology
- AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells
- (2014) Jing Zhao et al. International Journal of Medical Sciences
- Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium
- (2014) B. Trabert et al. JNCI-Journal of the National Cancer Institute
- Altered Expression of Multiple Genes Involved in Retinoic Acid Biosynthesis in Human Colorectal Cancer
- (2014) Ekaterina S. Kropotova et al. PATHOLOGY & ONCOLOGY RESEARCH
- Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3
- (2014) Jakub Hofman et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification
- (2013) Chih-Cheng Chen et al. BIOCHEMICAL PHARMACOLOGY
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway
- (2013) Ai-Mei Gao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
- (2013) Andy J. Liedtke et al. JOURNAL OF MEDICINAL CHEMISTRY
- AKR1C3 as a target in castrate resistant prostate cancer
- (2013) Adegoke O. Adeniji et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Unknown
- (2013) Agus Hamid et al. MOLECULAR MEDICINE
- Identification of aldo-keto reductases as NRF2-target marker genes in human cells
- (2013) Kyeong-Ah Jung et al. TOXICOLOGY LETTERS
- Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast
- (2012) Karin Lanthaler et al. BMC BIOLOGY
- Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
- (2012) Allan D Heibein et al. BMC CANCER
- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
- (2012) N. Mitsiades et al. CANCER RESEARCH
- Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers
- (2012) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Abiraterone Inhibits 3 -Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer
- (2012) R. Li et al. CLINICAL CANCER RESEARCH
- AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker
- (2012) Jun Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on N-Phenyl-Aminobenzoates and Their Structure–Activity Relationships
- (2012) Adegoke O. Adeniji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Aldo–keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells
- (2012) Robert C. Lyon et al. NEUROCHEMISTRY INTERNATIONAL
- Involvement of the aldo–keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms
- (2011) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
- (2011) Abena S. Agyeman et al. BREAST CANCER RESEARCH AND TREATMENT
- Human aldo–keto reductases 1B1 and 1B10: A comparative study on their enzyme activity toward electrophilic carbonyl compounds
- (2011) Yi Shen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Human aldo–keto reductase AKR7A2 protects against the cytotoxicity and mutagenicity of reactive aldehydes and lowers intracellular reactive oxygen species in hamster V79-4 cells
- (2011) Dan Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group
- (2011) Linlin Zhong et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)
- (2010) Jim A. Murray et al. BRITISH JOURNAL OF HAEMATOLOGY
- Resistance to platinum-based chemotherapy in lung cancer cell lines
- (2010) Jianli Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
- (2010) J. Hofland et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors
- (2010) Ossama El-Kabbani et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Proteomic analysis of cell lines to identify the irinotecan resistance proteins
- (2010) Xing-Chen Peng et al. JOURNAL OF BIOSCIENCES
- Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1)
- (2010) Ossama El-Kabbani et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
- (2009) A.Kenneth MacLeod et al. CARCINOGENESIS
- Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls
- (2009) Chun Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
- (2009) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis
- (2009) Jane Birtwistle et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
- (2009) Farhat L. Khanim et al. PLoS One
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
- (2008) M. Bacolod et al. CURRENT CANCER DRUG TARGETS
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
- (2008) Romana Novotna et al. TOXICOLOGY LETTERS
- Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: Role in the cell cycle and apoptosis
- (2007) Elisabet Selga et al. BIOCHEMICAL PHARMACOLOGY
- An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
- (2007) Michael C. Byrns et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More